(0) SAN FRANCISCO, CA / ACCESSWIRE / May 14, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today that effective May 12, 2021, the Company granted nonstatutory stock options for the purchase of up to 4,000 shares of the Company's common stock to New Employee 1, nonstatutory stock options for the purchase of up to 4,750 shares of the Company's common stock to New Employee 2, and nonstatutory stock options for the purchase of up to 40,000 shares of the Company's common stock to New Employee 3, as inducement awards under the Company's Inducement Award Plan. These nonstatutory stock options granted to the three new employees referenced above have an exercise price of $1.22 per share, representing the closing price of Jaguar's common stock as reported by Nasdaq on the grant date. These nonstatutory stock option awards have a ten-year term and vest over three years, with 25% of the shares vesting 12 months from the employee's date of hire, and thereafter, 3.125% vesting monthly for the remaining twenty-four months.